The Health Data, Technology, and Interoperability (HTI-4) Final Rule aims to strengthen the nation’s health IT ecosystem by ...
In today’s Pharma Pulse, the ACIP votes to end the decades-long universal hepatitis B birth dose recommendation; meanwhile, ...
This shift in data analysis enables what can be called a “precision medical affairs” approach. Instead of a one-size-fits-all ...
In today’s Pharma Pulse, Dr. Richard Pazdur retires from his CDER director role weeks after his appointment, and much more.
In the final part of his Pharma Commerce video interview, Ed Schoonveld, value and access advisor for Schoonveld Advisory and ...
In the first part of his Pharma Commerce video interview, Ed Schoonveld, value and access advisor for Schoonveld Advisory and ...
Cuban attributes the US’ high drug prices to PBMs—often considered the “middlemen” within the pharma supply chain—arguing ...
In the second part of his Pharma Commerce video interview, Ed Schoonveld, value and access advisor for Schoonveld Advisory ...
In today’s Pharma Pulse, a structured exercise program is proven to manage persistent long COVID symptoms, while Regeneron ...
The Health Data, Technology, and Interoperability (HTI-4) Final Rule aims to strengthen the nation’s health IT ecosystem by ...
Cencora—often known as being one of the “Big Three” wholesalers—is continuing to invest in its third-party logistics (3PL) ...
The agreement includes exemptions for UK-produced drugs and medical devices from Section 232 tariffs, but mandates a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback